0001209191-21-035364.txt : 20210524
0001209191-21-035364.hdr.sgml : 20210524
20210524165250
ACCESSION NUMBER: 0001209191-21-035364
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210520
FILED AS OF DATE: 20210524
DATE AS OF CHANGE: 20210524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mack David Henry
CENTRAL INDEX KEY: 0001341642
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39539
FILM NUMBER: 21955705
MAIL ADDRESS:
STREET 1: ONE EMBARCADERO CENTER, SUITE 3700
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PMV Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001699382
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463218129
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8 CLARKE DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
BUSINESS PHONE: (609) 642-6664
MAIL ADDRESS:
STREET 1: 8 CLARKE DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-05-20
0
0001699382
PMV Pharmaceuticals, Inc.
PMVP
0001341642
Mack David Henry
C/O PMV PHARMACEUTICALS, INC.
8 CLARKE DRIVE, SUITE 3
CRANBURY
NJ
08512
1
1
0
0
President and CEO
Common Stock
2021-05-20
4
M
0
7793
0.53
A
10263
D
Common Stock
2021-05-20
4
S
0
7793
35.6031
D
2470
D
Common Stock
2021-05-21
4
M
0
6207
0.53
A
8677
D
Common Stock
2021-05-21
4
S
0
6207
35.7083
D
2470
D
Common Stock
227915
I
See footnote
Common Stock
56978
I
See footnote
Stock Option (right to buy)
0.53
2021-05-20
4
M
0
7793
0.00
D
2025-05-11
Common Stock
7793
492867
D
Stock Option (right to buy)
0.53
2021-05-21
4
M
0
6207
0.00
D
2025-05-11
Common Stock
6207
485074
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.53 to $35.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.53 to $35.99, inclusive.
The shares are held of record by The Mack-Mulligan Revocable Trust, for which the Reporting Person serves as co-trustee.
The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust, for which the Reporting Person serves as co-trustee.
The shares subject to the option are fully vested and immediately exercisable.
/s/ David H. Mack
2021-05-24